Non-Small Cell Lung Cancer Center

This content has been reviewed and approved by

Chandra P. Belani, MD
Deputy Director, Penn State Cancer Institute
Miriam Beckner Professor of Medicine
Penn State University School of Medicine
 


Lung cancer is a very well-known form of cancer. It is the second most frequently diagnosed cancer in both men and women in the United States. In 2008, lung cancer will account for an estimated 15 percent of all new cancer cases in men and 14 percent in women, according to the American Cancer Society (ACS). Non-small cell lung cancer is one of the two most common types of lung cancer, accounting for approximately 87 percent of new cases, according to the ACS. 

Cancer of the lung is a growth of abnormal cells that usually starts in the bronchi (the main airways of the lungs). It can also begin in the trachea (the windpipe, which leads from the throat to the lungs) or in the smaller airways of the lungs. Nearly all lung cancers are carcinomas, meaning they begin in the lining or covering tissue of an organ. 

Other names for lung cancer include pulmonary carcinoma, bronchial carcinoma, and bronchoalveolar cell carcinoma. “Pulmonary” means “related to the lung,” and comes from the Latin word for lung (pulmo). “Bronchoalveolar” describes the small lung structures that branch out from the bronchi.

The leading cause of lung cancer is smoking tobacco products. Smoking causes more than 90 percent of all lung cancers. However, not all people who smoke develop lung cancer, and not all cases of lung cancer are caused by smoking. Other risk factors for lung cancer include breathing secondary smoke (smoke from other people’s tobacco use), smoking marijuana, and exposure to asbestos or other harmful agents, such as radioactivity, arsenic, vinyl chloride, mustard gas, radon gas, or diesel exhaust.

This content was last modified on November 16, 2007 .
» Read More Introduction to Non-Small Cell Lung Cancer
Hot Topics

Working During Treatment

The things you need to know before making your decision about returning to work.



  • Wellbeing
    The Seven Levels of Healing® and other ways to promote healthy living
  • Nutrition
    Ways to stay nourished and eat well during, and after treatment
  • Financial Support
    Navigating the payment maze and understanding health care costs
 
Community
Latest posts on our message boards:
 

Randy Pausch
  • Randy Pausch
    Professor and cancer patient, Randy shares the famous "Last Lecture"
Arnold Palmer
 
Patti LaBelle
The Sever Levels of Healing®
 
Nutrition
  • Nutrition
    Ways to stay nourished and eat well during, and after, treatment
Rudi Giuliani
  • Rudi Giuliani
    The former New York City Mayor shares his inspirational story
 
 
Latest Non-Small Cell Lung Cancer News
Bone drug has benefits in cancer patients

July 18, 2008 — NEW YORK (Reuters Health) - The bone-strengthening drug zoledronic acid not only reduces fracture risk in patients with cancer that has spread to the bones, it also improves overall survival, according to the results of a retrospective analysis of three large studies.

Doctors extract cancer cells from blood sample

July 3, 2008 — BOSTON (Reuters) - An experimental process that snags lung cancer cells from a blood sample could give doctors real-time feedback on the most effective therapy, researchers reported on Wednesday.

Erbitux adds 5 weeks to lung cancer survival

June 2, 2008 — CHICAGO (Reuters) - Lung cancer patients treated in a large clinical trial with ImClone Systems Inc's Erbitux and chemotherapy lived about five weeks longer than patients treated with chemotherapy alone, according to study results released on Saturday.

Select news items provided by Reuters Health